111 related articles for article (PubMed ID: 23507480)
1. Epigenetics in hematology: introduction.
Beris P
Semin Hematol; 2013 Jan; 50(1):15. PubMed ID: 23507480
[No Abstract] [Full Text] [Related]
2. [Epigenetic regulators as novel therapeutic targets in hematology/oncology].
Mahlknecht U; Hoelzer D
Dtsch Med Wochenschr; 2003 Nov; 128(46):2423-6. PubMed ID: 14614656
[No Abstract] [Full Text] [Related]
3. [Epigenetics in hematological disorders].
Furukawa Y
Rinsho Ketsueki; 2008 Oct; 49(10):1472-82. PubMed ID: 18833931
[No Abstract] [Full Text] [Related]
4. Epigenetics in the hematologic malignancies.
Fong CY; Morison J; Dawson MA
Haematologica; 2014 Dec; 99(12):1772-83. PubMed ID: 25472952
[TBL] [Abstract][Full Text] [Related]
5. [Epigenetics].
Tabe Y
Nihon Rinsho; 2012 Apr; 70 Suppl 2():86-90. PubMed ID: 23133933
[No Abstract] [Full Text] [Related]
6. Advances in understanding the molecular pathogenesis of neoplastic hematologic disorders.
Williams JL
Clin Lab Sci; 2004; 17(4):221-2. PubMed ID: 15559728
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic dysregulation in hematological malignancies.
Iwama A
Int J Hematol; 2017 Jan; 105(1):5-6. PubMed ID: 27822916
[No Abstract] [Full Text] [Related]
8. Therapeutic epigenetics: an emerging clinical approach to hematologic malignancies.
Clin Adv Hematol Oncol; 2005 Mar; 3(3 Suppl 1):1-10; quiz 11-2. PubMed ID: 21438190
[No Abstract] [Full Text] [Related]
9. Perspectives and future directions for epigenetics in hematology.
Goodell MA; Godley LA
Blood; 2013 Jun; 121(26):5131-7. PubMed ID: 23692857
[TBL] [Abstract][Full Text] [Related]
10. Genetics and epigenetics of 1q rearrangements in hematological malignancies.
Fournier A; Florin A; Lefebvre C; Solly F; Leroux D; Callanan MB
Cytogenet Genome Res; 2007; 118(2-4):320-7. PubMed ID: 18000386
[TBL] [Abstract][Full Text] [Related]
11. Role of epigenetic changes in hematological malignancies.
Lehmann U; Brakensiek K; Kreipe H
Ann Hematol; 2004 Mar; 83(3):137-52. PubMed ID: 15064862
[TBL] [Abstract][Full Text] [Related]
12. Guest editorial: Epigenetics of hematopoiesis and hematological malignancies.
Iwama A
Int J Hematol; 2012 Oct; 96(4):403-4. PubMed ID: 23015418
[No Abstract] [Full Text] [Related]
13. Epigenetic abnormalities and therapies for hematological malignancies.
Kitamura T
Int J Hematol; 2019 Aug; 110(2):147-149. PubMed ID: 31280414
[No Abstract] [Full Text] [Related]
14. Epigenetics and New Therapies in Cancer--An ESO-CNIO Conference. 29-30 November 2007, Madrid, Spain.
Lyko F
IDrugs; 2008 Feb; 11(2):79-81. PubMed ID: 18240087
[No Abstract] [Full Text] [Related]
15. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
[TBL] [Abstract][Full Text] [Related]
16. An emerging role for retinoid X receptor α in malignant hematopoiesis.
Thomas M; Sukhai MA; Kamel-Reid S
Leuk Res; 2012 Sep; 36(9):1075-81. PubMed ID: 22710246
[TBL] [Abstract][Full Text] [Related]
17. [Experimental hematology bridging the gap between laboratory and clinic: hope of hematology].
Chen Z; Chen SJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):1-21. PubMed ID: 18315892
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic immunomodulation of hematopoietic malignancies.
Gattei V; Fonsatti E; Sigalotti L; Degan M; Di Giacomo AM; Altomonte M; Calabrò L; Maio M
Semin Oncol; 2005 Oct; 32(5):503-10. PubMed ID: 16210091
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics is a fascinating field of modern biology. Preface.
Herceg Z; Ushijima T
Adv Genet; 2010; 71():xi-xii. PubMed ID: 20933123
[No Abstract] [Full Text] [Related]
20. Overexpression of p16INK4A and p14ARF in haematological malignancies.
Güran S; Beyan C
Clin Lab Haematol; 2004 Aug; 26(4):303. PubMed ID: 15279671
[No Abstract] [Full Text] [Related]
[Next] [New Search]
